11.350
−1,30%
2026-10-19
Fundamental Analysis
63 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +80.5% | +3.5% | 1 / 3 | +61.3% | +1.53 pp | +0.99 pp | +10.4% | 0.23 | 8.89 | 433 | +61,3% | 28,1 | +90,6% | 8.89 | 15.39 | −42,3% |
| Pts | 12 | 0 | 4 | 12 | 8 | 8 | 0 | 12 | 12 | |||||||
Valuation annotation:Price: 11.350 (close price on 2026-10-19)EPS (TTM): 1.277
Financial charts
1.Revenue & growth
VND bn433Q2/26
1.Revenue & growth
VND bn433Q2/26
2.Profit & growth
VND bn27,8Q2/26
3.Profit mix (Penman)
VND bn169Q2/26
4.Margins & cost structure
%17.5%Q2/26
5.Returns & cash cycle
% · days8.7%Q2/26
6.Earnings quality & cash
VND bn
7.Asset structure
VND bn2.383Q2/26
8.Funding & debt health
VND bn · times2.383Q2/26
9.Revenue backlog
VND bn128Q2/26
10.Valuation
times · %9,0×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %253Q2/26
Adjusted EPS growth, latest quarter
80.5%
Average adjusted EPS growth, 3 quarters
1.3%
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
4.9%
Source: vnstockData through Q2/26